fda semaglutide warning november 2025 warns Novo Nordisk over unreported Ozempic and Wegovy side effects U.S. FDA finds no evidence

It is a clinically proven treatment that helps adults with obesity lose weight while also reducing the risk of cardiovascular events in patients who also have heart disease. 1 What Are the Legal and Market Implications

Acetaminophen is generally considered the safer first-line option for tirzepatide users

There has yet to be a study which examines how much time needs to pass before any benefits obtained from semaglutide are reversed following treatment discontinuation

Women of reproductive potential should be counseled about these risks and should use effective contraception during treatment

If lunch was low on protein, you'd make it up at dinner